<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39333984</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Changes in incidence and clinical features of tuberculosis with regard to the COVID-19 outbreak in Southern Iran.</ArticleTitle><Pagination><StartPage>1043</StartPage><MedlinePgn>1043</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1043</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-024-09947-0</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a significant global health threat. It results in substantial mortality and may be underrecognized due to insufficient screening and diagnostic challenges. Furthermore, TB's impact is closely linked to complex socioeconomic and healthcare factors. The COVID-19 pandemic has exacerbated these challenges due to similarities in clinical presentation and transmission dynamics with TB. Socioeconomic factors such as limited access to healthcare services, resource constraints, and social stigma further complicate TB management. Historically, TB faced increased burdens during natural disasters, wars, and pandemics. This study analyzes TB incidence changes, emphasizing the crucial need for timely diagnosis within the context of COVID-19 measures.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">This cross-sectional study, conducted at Shiraz's TB referral center in Southern Iran, covered the period from January 1, 2018, to December 31, 2022. We analyzed patient data, including epidemiological and demographic factors, clinical and radiological features, and treatment outcomes. Data were compared between the pre-COVID-19 pandemic era and the COVID-19 pandemic era (from March 2020), using standard and regression analyses. A P-value of less than 0.05 was considered statistically significant.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We analyzed 388 TB patients with a mean age of 48.38 ± 20.53 years, including 264 pulmonary cases (68.0%). The highest incidence of TB was recorded in 2019, representing 27.6% of the cases. During the COVID-19 era, logistic regression analysis identified significant associations with higher education levels (P = 0.032; OR = 1.380; 95% CI: 1.028-1.851), a decrease in symptoms such as sputum production (P = 0.004; OR = 0.342; 95% CI: 0.166-0.705) and chills (P = 0.036; OR = 0.282; 95% CI: 0.087-0.919), and an increase in symptoms of fatigue (P = 0.006; OR = 2.856; 95% CI: 1.358-6.005).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The COVID-19 pandemic has had a prolonged impact on TB cases in our country, resulting in a reduction in reported cases due to challenges in quarantine and screening. However, it has also led to a shift in TB patterns and a potential increase in latent TB cases and future mortality rates. Addressing the repercussions requires enhanced control strategies, prioritized service delivery, and secured funding for intensified case finding, expanded contact-tracing, community engagement, digital health tools, and uninterrupted access to medications.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fallahi</LastName><ForeName>Mohammad Javad</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Science, Shiraz, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazemi</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeighami</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahriarirad</LastName><ForeName>Reza</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Science, Shiraz, Iran. r.shahriari1995@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran. r.shahriari1995@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014376" MajorTopicYN="Y">Tuberculosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cross-sectional studies</Keyword><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Epidemiologic factors</Keyword><Keyword MajorTopicYN="N">Iran</Keyword><Keyword MajorTopicYN="N">Tuberculosis</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>0</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39333984</ArticleId><ArticleId IdType="pmc">PMC11430532</ArticleId><ArticleId IdType="doi">10.1186/s12879-024-09947-0</ArticleId><ArticleId IdType="pii">10.1186/s12879-024-09947-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global Tuberculosis Report. 2023 [https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023]</Citation></Reference><Reference><Citation>Jarand J, Shean K, O’Donnell M, Loveday M, Kvasnovsky C, Van der Walt M, Adams S, Willcox P, O’Grady J, Zumla A, et al. Extensively drug-resistant tuberculosis (XDR-TB) among health care workers in South Africa. Tropical Med Int Health. 2010;15(10):1179–84.</Citation><ArticleIdList><ArticleId IdType="pubmed">20831672</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudor C, Van der Walt M, Margot B, Dorman SE, Pan WK, Yenokyan G, Farley JE. Tuberculosis among health care workers in KwaZulu-Natal, South Africa: a retrospective cohort analysis. BMC Public Health. 2014;14(1):1–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4161912</ArticleId><ArticleId IdType="pubmed">25174848</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Donnell MR, Jarand J, Loveday M, Padayatchi N, Zelnick J, Werner L, Naidoo K, Master I, Osburn G, Kvasnovsky C, et al. High incidence of Hospital admissions with Multidrug-resistant and extensively drug-resistant tuberculosis among South African Health Care workers. Ann Intern Med. 2010;153(8):516–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3074259</ArticleId><ArticleId IdType="pubmed">20956708</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi R, Reingold AL, Menzies D, Pai M. Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med. 2006;3(12):e494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1716189</ArticleId><ArticleId IdType="pubmed">17194191</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasiri MJ, Dabiri H, Darban-Sarokhalil D, Rezadehbashi M, Zamani S. Prevalence of drug-resistant tuberculosis in Iran: systematic review and meta-analysis. Am J Infect Control. 2014;42(11):1212–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25242634</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH. Global tuberculosis report 2013: World health organization; 2013.</Citation></Reference><Reference><Citation>Organization WH. Global hepatitis report 2017. World Health Organization; 2017.</Citation></Reference><Reference><Citation>Bay V, Tabarsi P, Rezapour A, Marzban S, Zarei E. Cost of Tuberculosis Treatment: evidence from Iran’s Health System. Osong Public Health Res Perspect. 2017;8(5):351–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5678196</ArticleId><ArticleId IdType="pubmed">29164047</ArticleId></ArticleIdList></Reference><Reference><Citation>YektaKooshali MH, Movahedzadeh F, Foumani AA, Sabati H, Jafari A. Is latent tuberculosis infection challenging in Iranian health care workers? A systematic review and meta-analysis. PLoS ONE. 2019;14(10):e0223335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6776393</ArticleId><ArticleId IdType="pubmed">31581258</ArticleId></ArticleIdList></Reference><Reference><Citation>Proenca R, Mattos Souza F, Lisboa Bastos M, Caetano R, Braga JU, Faerstein E, Trajman A. Active and latent tuberculosis in refugees and asylum seekers: a systematic review and meta-analysis. BMC Public Health. 2020;20(1):838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7268459</ArticleId><ArticleId IdType="pubmed">32493327</ArticleId></ArticleIdList></Reference><Reference><Citation>Basnyat B, Caws M, Udwadia Z. Tuberculosis in South Asia: a tide in the affairs of men. Multidiscip Respir Med. 2018;13:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5868053</ArticleId><ArticleId IdType="pubmed">29599974</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas J, Aman J, Nurunnabi M, Bano S. The Impact of Social Media on Learning Behavior for Sustainable Education: evidence of students from selected universities in Pakistan. Sustainability. 2019;11(6):1683.</Citation></Reference><Reference><Citation>Abbas J, Aqeel M, Abbas J, Shaher B, Sundas AJ, Zhang J. The moderating role of social support for marital adjustment, depression, anxiety, and stress: evidence from Pakistani working and nonworking women. J Affect Disord. 2019;244:231–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30173879</ArticleId></ArticleIdList></Reference><Reference><Citation>Karadakhy K, Othman N, Ibrahimm F, Saeed AA, Amin AAH. Tuberculosis in Sulaimaniyah, Iraqi Kurdistan: a detailed analysis of cases registered in Treatment centers. Tanaffos. 2016;15(4):197–204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5410115</ArticleId><ArticleId IdType="pubmed">28469675</ArticleId></ArticleIdList></Reference><Reference><Citation>Farnia P, Mohammadi F, Masjedi MR, Varnerot A, Zarifi AZ, Tabatabee J, Douraghei M, Ghazisaeedi K, Mansorri D, Bahadori M, et al. Evaluation of tuberculosis transmission in Tehran: using RFLP and spoloigotyping methods. J Infect. 2004;49(2):94–101.</Citation><ArticleIdList><ArticleId IdType="pubmed">15236915</ArticleId></ArticleIdList></Reference><Reference><Citation>Asgharzadeh M, Shahbabian K, Samadi Kafil H, Rafi A. Use of DNA fingerprinting in identifying the source case of tubercolosis in East Azarbaijan province of Iran. J Med Sci. 2007;7(3):418–21.</Citation></Reference><Reference><Citation>Shahriarirad R, Fallahi MJ. TB and the COVID-19 pandemic: brothers in arms against lung health. Int J Tuberc Lung Dis. 2020;24(10):1126–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33126954</ArticleId></ArticleIdList></Reference><Reference><Citation>Zurcher K, Zwahlen M, Ballif M, Rieder HL, Egger M, Fenner L. Influenza pandemics and tuberculosis mortality in 1889 and 1918: analysis of historical data from Switzerland. PLoS ONE. 2016;11(10):e0162575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051959</ArticleId><ArticleId IdType="pubmed">27706149</ArticleId></ArticleIdList></Reference><Reference><Citation>Vynnycky E, Fine PE. Interpreting the decline in tuberculosis: the role of secular trends in effective contact. Int J Epidemiol. 1999;28(2):327–34.</Citation><ArticleIdList><ArticleId IdType="pubmed">10342699</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163(9):1009–21.</Citation><ArticleIdList><ArticleId IdType="pubmed">12742798</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichikawa M, Nakahara S, Wakai S, Hong-Jen C, Huang N. Lowered Tuberculosis notifications and deterred health care seeking during the SARS epidemic in Hong Kong/Chang and Huang respond. Am J Public Health. 2005;95(6):933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1449283</ArticleId><ArticleId IdType="pubmed">15914811</ArticleId></ArticleIdList></Reference><Reference><Citation>Delamou A, Delvaux T, El Ayadi AM, Beavogui AH, Okumura J, Van Damme W, De Brouwere V. Public health impact of the 2014–2015 Ebola outbreak in West Africa: seizing opportunities for the future. BMJ Glob Health. 2017;2(2):e000202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5435258</ArticleId><ArticleId IdType="pubmed">28589018</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfaraj SH, Al-Tawfiq JA, Altuwaijri TA, Memish ZA. Middle East Respiratory Syndrome Coronavirus and Pulmonary Tuberculosis Coinfection: implications for infection control. Intervirology. 2017;60(1–2):53–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179530</ArticleId><ArticleId IdType="pubmed">28683463</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadolini M, Codecasa LR, Garcia-Garcia JM, Blanc FX, Borisov S, Alffenaar JW, Andrejak C, Bachez P, Bart PA, Belilovski E et al. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J 2020, 56(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7251245</ArticleId><ArticleId IdType="pubmed">32457198</ArticleId></ArticleIdList></Reference><Reference><Citation>Motta I, Centis R, D’Ambrosio L, Garcia-Garcia JM, Goletti D, Gualano G, Lipani F, Palmieri F, Sanchez-Montalva A, Pontali E, et al. Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020;26(4):233–40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7221402</ArticleId><ArticleId IdType="pubmed">32411943</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH. World Health Organization (WHO) information note tuberculosis and COVID-19. Geneva: World Health Organization; 2020.</Citation></Reference><Reference><Citation>Ong CWM, Migliori GB, Raviglione M, MacGregor-Skinner G, Sotgiu G, Alffenaar JW, Tiberi S, Adlhoch C, Alonzi T, Archuleta S et al. Epidemic and pandemic viral infections: impact on tuberculosis and the lung: a consensus by the World Association for Infectious Diseases and Immunological disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). Eur Respir J 2020, 56(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7527651</ArticleId><ArticleId IdType="pubmed">32586885</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliori GB, Thong PM, Alffenaar JW, Denholm J, Tadolini M, Alyaquobi F, Blanc FX, Buonsenso D, Cho JG, Codecasa LR et al. Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study. Eur Respir J 2021, 58(5).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8581650</ArticleId><ArticleId IdType="pubmed">34446465</ArticleId></ArticleIdList></Reference><Reference><Citation>Stop T. Partnership; Imperial College; Avenir Health; Johns Hopkins University; USAID. The potential impact of the Covid-19 response on tuberculosis in high-burden countries: a modelling analysis Geneva. Stop TB Partnership; 2020.</Citation></Reference><Reference><Citation>Soo RJJ, Chiew CJ, Ma S, Pung R, Lee V. Decreased influenza incidence under COVID-19 Control measures, Singapore. Emerg Infect Dis. 2020;26(8):1933–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392467</ArticleId><ArticleId IdType="pubmed">32339092</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo SC, Shih SM, Chien LH, Hsiung CA. Collateral benefit of COVID-19 Control measures on Influenza Activity, Taiwan. Emerg Infect Dis. 2020;26(8):1928–30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392415</ArticleId><ArticleId IdType="pubmed">32339091</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders MJ, Evans CA. Fighting poverty to prevent tuberculosis. Lancet Infect Dis. 2016;16(4):395–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26725447</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter DJ, Glaziou P, Lonnroth K, Siroka A, Floyd K, Weil D, Raviglione M, Houben R, Boccia D. The impact of social protection and poverty elimination on global tuberculosis incidence: a statistical modelling analysis of sustainable development goal 1. Lancet Glob Health. 2018;6(5):e514–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5968370</ArticleId><ArticleId IdType="pubmed">29580761</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliori GB, Garcia-Basteiro AL. Predicting the effect of improved socioeconomic health determinants on the tuberculosis epidemic. Lancet Glob Health. 2018;6(5):e475–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">29580762</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis–rapid diagnostics for tuberculosis detection. World Health Organization; 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">38527162</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Xu C, Ren J, Wu W, Zhao X, Chao L, Liang W, Yao S. Secular seasonality and Trend forecasting of tuberculosis incidence rate in China using the Advanced Error-Trend-Seasonal Framework. Infect Drug Resist. 2020;13:733–47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7062399</ArticleId><ArticleId IdType="pubmed">32184635</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardell E, Dharmadhikari A. Turning off the spigot: reducing drug-resistant tuberculosis transmission in resource-limited settings. Int J Tuberc Lung Dis. 2010;14(10):1233–43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3709569</ArticleId><ArticleId IdType="pubmed">20843413</ArticleId></ArticleIdList></Reference><Reference><Citation>Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999;282(7):677–86.</Citation><ArticleIdList><ArticleId IdType="pubmed">10517722</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjune G. Tuberculosis in the 21st century: an emerging pandemic? Norsk Epidemiologi 2005, 15(2).</Citation></Reference><Reference><Citation>Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, Hamlet A, Smith JA, Winskill P, Verity R, et al. Potential impact of the COVID-19 pandemic on HIV, Tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020;8(9):e1132–41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7357988</ArticleId><ArticleId IdType="pubmed">32673577</ArticleId></ArticleIdList></Reference><Reference><Citation>Visca D, Ong CWM, Tiberi S, Centis R, D’Ambrosio L, Chen B, Mueller J, Mueller P, Duarte R, Dalcolmo M, et al. Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects. Pulmonology. 2021;27(2):151–65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7825946</ArticleId><ArticleId IdType="pubmed">33547029</ArticleId></ArticleIdList></Reference><Reference><Citation>Group TC-GS. Tuberculosis and COVID-19 co-infection: description of the global cohort. Eur Respir J. 2022;59(3):2102538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8588566</ArticleId><ArticleId IdType="pubmed">34764184</ArticleId></ArticleIdList></Reference><Reference><Citation>Pai M, Olatunbosun-Alakija A. Vax the world. In., vol. 374: American Association for the Advancement of Science; 2021: 1031–1031.</Citation><ArticleIdList><ArticleId IdType="pubmed">34822275</ArticleId></ArticleIdList></Reference><Reference><Citation>Dheda K, Perumal T, Moultrie H, Perumal R, Esmail A, Scott AJ, Udwadia Z, Chang KC, Peter J, Pooran A, et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions. Lancet Respir Med. 2022;10(6):603–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8942481</ArticleId><ArticleId IdType="pubmed">35338841</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliori GB, Tiberi S, Garcia-Basteiro AL, Duarte R. Tuberculosis and its future in the COVID-19 era: the Pulmonology series 2021. Pulmonology. 2021;27(2):94–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7670961</ArticleId><ArticleId IdType="pubmed">33272908</ArticleId></ArticleIdList></Reference><Reference><Citation>Akkerman O, Aleksa A, Alffenaar JW, Al-Marzouqi NH, Arias-Guillen M, Belilovski E, Bernal E, Boeree MJ, Borisov SE, Bruchfeld J, et al. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: a global feasibility study. Int J Infect Dis. 2019;83:72–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">30953827</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuaid CF, Vassall A, Cohen T, Fiekert K, White RG. The impact of COVID-19 on TB: a review of the data. Int J Tuberc Lung Dis. 2021;25(6):436–46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8171247</ArticleId><ArticleId IdType="pubmed">34049605</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH. Programmatic innovations to address challenges in tuberculosis prevention and care during the COVID-19 pandemic. 2021.</Citation></Reference><Reference><Citation>Tavakoli A. Incidence and prevalence of tuberculosis in Iran and neighboring countries. Zahedan J Res Med Sci 2017, 19(7).</Citation></Reference><Reference><Citation>Migliori GB, Thong PM, Akkerman O, Alffenaar JW, Alvarez-Navascues F, Assao-Neino MM, Bernard PV, Biala JS, Blanc FX, Bogorodskaya EM, et al. Worldwide effects of Coronavirus Disease Pandemic on Tuberculosis services, January-April 2020. Emerg Infect Dis. 2020;26(11):2709–12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7588533</ArticleId><ArticleId IdType="pubmed">32917293</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdool Karim Q, Abdool Karim SS. COVID-19 affects HIV and Tuberculosis care. Science. 2020;369(6502):366–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32703860</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandavilli A. The biggest monster’is spreading. And it’s not the coronavirus. New York Times 2020, 3.</Citation></Reference><Reference><Citation>Cilloni L, Fu H, Vesga JF, Dowdy D, Pretorius C, Ahmedov S, Nair SA, Mosneaga A, Masini E, Sahu S, et al. The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis. EClinicalMedicine. 2020;28:100603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7584493</ArticleId><ArticleId IdType="pubmed">33134905</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). Brazilian J Implantology Health Sci 2020, 2(3).</Citation></Reference><Reference><Citation>Visca D, Tiberi S, Pontali E, Spanevello A, Migliori GB. Tuberculosis in the time of COVID-19: quality of life and digital innovation. Volume 56. Eur Respiratory Soc; 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7278505</ArticleId><ArticleId IdType="pubmed">32513783</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah S, Daud H, Dass SC, Fanaee TH, Kausarian H, Khalil A. Space-time clustering characteristics of tuberculosis in Khyber Pakhtunkhwa Province, Pakistan, 2015–2019. Int J Environ Res Public Health. 2020;17(4):1413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7068355</ArticleId><ArticleId IdType="pubmed">32098247</ArticleId></ArticleIdList></Reference><Reference><Citation>Moradi M, Arababadi MK, Hassanshahi G. Tuberculosis in the Afghan immigrant in Kerman province of Iran. 2008.</Citation></Reference><Reference><Citation>Tabrizi J, Rostami FF, Ahmadi S, Dolatabad SS. Socio-demographic factors affecting the prevalence of tuberculosis in Iran. 2014.</Citation></Reference><Reference><Citation>Azni SM, Mansourian AA, Nokandeh Z. Epidemiological study of tuberculosis in Damghan city (Iran) during 2003–2007. 2008.</Citation></Reference><Reference><Citation>Doosti A, Nasehi M, Moradi G, Roshani D, Sharafi S, Ghaderi E. The pattern of tuberculosis in Iran: A National Cross-sectional Study. Iran J Public Health. 2023;52(1):193–200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9941440</ArticleId><ArticleId IdType="pubmed">36824245</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiani B, Raouf Rahmati A, Bergquist R, Hashtarkhani S, Firouraghi N, Bagheri N, Moghaddas E, Mohammadi A. Spatio-temporal epidemiology of the tuberculosis incidence rate in Iran 2008 to 2018. BMC Public Health. 2021;21(1):1093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8186231</ArticleId><ArticleId IdType="pubmed">34098917</ArticleId></ArticleIdList></Reference><Reference><Citation>MR Kadivar M, Ghaneh Shirazi R, Khavandegaran F, Karimi M. Epidemiology of tuberculosis among Afghan immigrants in Fars province, southern Islamic Republic of Iran. EMHJ-Eastern Mediterranean Health Journal, 13 (4), 758–764, 2007 2007.</Citation><ArticleIdList><ArticleId IdType="pubmed">17955756</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabatabaee H, Hassan Zadeh J, Younes Nia F, Ali Akbarpoor M, Javanmard S, Honarvar B. Spatio-temporal pattern of tuberculosis in the regions supervised by Shiraz University of Medical Sciences 2006–2012. Iran J Public Health. 2015;44(9):1253–61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4645783</ArticleId><ArticleId IdType="pubmed">26587500</ArticleId></ArticleIdList></Reference><Reference><Citation>Moosazadeh M, Khanjani N, Bahrampour A, Nasehi M. Does Tuberculosis have a seasonal pattern among migrant population entering Iran? Int J Health Policy Manag. 2014;2(4):181–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4025095</ArticleId><ArticleId IdType="pubmed">24847484</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallahi MJ, Mirdamadi A, Moghadami M. Pulmonary tuberculosis seasonality survey in Fars Province, South of Iran. Shiraz E-Medical J. 2019;20(9):e86348.</Citation></Reference><Reference><Citation>Paynter S, Ware RS, Sly PD, Williams G, Weinstein P. Seasonal immune modulation in humans: observed patterns and potential environmental drivers. J Infect. 2015;70(1):1–10.</Citation><ArticleIdList><ArticleId IdType="pubmed">25246360</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh GC, Hawthorne G, Turner AM, Kunst H, Dedicoat M. Tuberculosis incidence correlates with sunshine: an ecological 28-year time series study. PLoS ONE. 2013;8(3):e57752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3590299</ArticleId><ArticleId IdType="pubmed">23483924</ArticleId></ArticleIdList></Reference><Reference><Citation>Dookie N, Padayatchi N, Naidoo K. Tuberculosis elimination in the era of Coronavirus Disease 2019 (COVID-19): a moving target. Clin Infect Dis. 2022;74(3):509–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543364</ArticleId><ArticleId IdType="pubmed">32927477</ArticleId></ArticleIdList></Reference><Reference><Citation>Dheda K, Jaumdally S, Davids M, Chang J-W, Gina P, Pooran A, Makambwa E, Esmail A, Vardas E, Preiser W. Diagnosis of COVID-19: considerations, controversies and challenges in South Africa. Wits J Clin Med. 2020;2(Si1):3–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8203071</ArticleId><ArticleId IdType="pubmed">34240023</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>